NDC Labeler Biomarin Pharmaceutical Inc.

Biomarin Pharmaceutical Inc. labeler's code is 68135. The labeler has 20 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
68135-020Naglazyme GalsulfaseSolutionIntravenousHuman Prescription DrugACTIVE
68135-058Palynziq Pegvaliase-pqpzInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
68135-082Voxzogo 0.4mg VosoritideKitHuman Prescription DrugACTIVE
68135-100Vimizim Elosulfase AlfaInjection, Solution, ConcentrateIntravenousHuman Prescription DrugACTIVE
68135-119Voxzogo 0.56mg VosoritideKitHuman Prescription DrugACTIVE
68135-181Voxzogo 1.2mg VosoritideKitHuman Prescription DrugACTIVE
68135-300Kuvan Sapropterin DihydrochlorideTabletOralHuman Prescription DrugACTIVE
68135-301Kuvan Sapropterin DihydrochloridePowder, For SolutionOralHuman Prescription DrugACTIVE
68135-482Kuvan Sapropterin DihydrochloridePowder, For SolutionOralHuman Prescription DrugACTIVE
68135-673Palynziq Pegvaliase-pqpzInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
68135-756Palynziq Pegvaliase-pqpzInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
68135-811Brineura Cerliponase AlfaKitHuman Prescription DrugACTIVE
68135-927Roctavian Valoctocogene Roxaparvovec-rvoxInjection, SolutionIntravenousHuman Prescription DrugACTIVE
68135-000 LaronidaseInjection, Solution, ConcentrateDrug For Further ProcessingUNFINISHED
68135-020 GalsulfaseSolutionDrug For Further ProcessingUNFINISHED
68135-060 Pegvaliase-pqpzInjection, SolutionDrug For Further ProcessingUNFINISHED
68135-062 VosoritideInjection, Solution, ConcentrateDrug For Further ProcessingUNFINISHED
68135-100 Elosulfase AlfaInjection, Solution, ConcentrateDrug For Further ProcessingUNFINISHED
68135-117 Pegvaliase-pqpzInjection, SolutionDrug For Further ProcessingUNFINISHED
68135-502 Cerliponase AlfaInjection, SolutionDrug For Further ProcessingUNFINISHED